Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...

Zero Trust isn't magic. It's a specific set of architectural components working together—policy engine, identity fabric, ...

-- Company Plans to Submit the MOLBREEVI Marketing Authorization Applications (MAAs) for Autoimmune PAP to the European Medicines Agency (EMA) and the Medicines and Healthcare Products Regulatory ...

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

BJP MLA RK Imo Singh urged tweaks to Manipur’s PAP process for ease and transparency Singh suggested online applications, clear timelines, and priority for urgent cases Requests include exemptions for ...

AFPs collaborate with self-funded health plans to manage specialty medication costs, often excluding coverage and requiring alternative sourcing. They impact market access strategies, patient services ...

You can still get a Pap smear while on your period, but heavy bleeding might affect test accuracy. Light bleeding or spotting usually won't affect Pap smear results. Healthcare providers generally ...

Federal guidelines are expanding the options for cervical cancer screenings beyond the often-disliked Pap smear. According to new recommendations released Monday by the Health Resources and Services ...

In December 2024, the Government of India quietly reimposed the Protected Area Permit (PAP) regime on Manipur, Nagaland and Mizoram – the states where the requirement had been lifted since 2011.

-- The BLA was Resubmitted with FUJIFILM Biotechnologies (Fujifilm) as the Drug Substance Manufacturer and Priority Review was Requested -- MOLBREEVI was granted Fast Track and Breakthrough Therapy ...